Effect of intravenous omega-3 fatty acids on outcome of patients with sepsis: a systematic review and meta-analysis

杨广宇,王璐,王宇,张驰,曾俊,江华,孙明伟

DOI: https://doi.org/10.3877/cma.j.issn.1673-9450.2023.02.010

2023-01-01

Abstract:Objective:To systematically review the clinical efficacy of intravenous omega-3 fatty acids supplemented for septic patients.Methods:The relevant randomized controlled trails (RCTs) from 1 January 2000 to 31 January 2023 were searched in online databases, including CNKI, WanFang Data, SinoMed, PubMed, EMBase, Web of Science and Cochrane Library. The primary outcome was the 28-day mortality. The secondary outcome included the length of ICU stay, the length of hospital stays and the length of mechanical ventilation. The quality of these included studies was evaluated by the modified Jadad score scale. The bias was assessed by the Cochrane risk-of-bias tool for randomized trial. The data was analyzed using RevMan 5.4.Results:Forty-six relevant literatures were obtained from initial literature retrieve and were screened systematically after preliminary screening. A total of 5 RCT studies involving 266 patients met all inclusion criteria and were enrolled systematic review. Meta-analysis indicated that intravenous administration of omega-3 fatty acids reduced the 28-day mortality [RR=0.52, 95%CI (0.33, 0.83), P=0.006]. And the length of ICU stay was reduced for patients received intravenous omega-3 fatty acids [MD=-4.40, 95%CI (-8.68, -0.13), P=0.04]. In addition, there was no difference on the duration of mechanical ventilation between the two groups [MD=-1.29, 95%CI (-3.70, 1.13), P=0.30].Conclusion:Intravenous supplementation of omega-3 fatty acids effectively reduce short-term mortality of patients with sepsis, shorten the length of stay in ICU, which has a positive effect on improving the clinical outcome of patients with sepsis, but its impact on the duration of mechanical ventilation is not significant.